EE200100276A - Pressurized metered dose inhalers (MDI) - Google Patents

Pressurized metered dose inhalers (MDI)

Info

Publication number
EE200100276A
EE200100276A EEP200100276A EEP200100276A EE200100276A EE 200100276 A EE200100276 A EE 200100276A EE P200100276 A EEP200100276 A EE P200100276A EE P200100276 A EEP200100276 A EE P200100276A EE 200100276 A EE200100276 A EE 200100276A
Authority
EE
Estonia
Prior art keywords
mdi
metered dose
dose inhalers
pressurized metered
pressurized
Prior art date
Application number
EEP200100276A
Other languages
Estonian (et)
Inventor
Lewis David
Ganderton David
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to ITMI982559 priority Critical patent/IT1303789B1/en
Priority to ITMI991712 priority patent/IT1313582B1/en
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Priority to PCT/EP1999/009002 priority patent/WO2000030608A1/en
Publication of EE200100276A publication Critical patent/EE200100276A/en
Publication of EE04259B1 publication Critical patent/EE04259B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100276(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/958Drug, bio-affecting and body treating compositions for smoking or inhaling
EEP200100276A 1998-11-25 1999-11-23 Pressurized metered dose inhalers (MDI) EE04259B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI982559 IT1303789B1 (en) 1998-11-25 1998-11-25 New pressured metered dose inhalers (MDI) in which all the internal surfaces of the inhalers are stainless steel, anodised aluminum or are lined with an inert organic coating are new
ITMI991712 IT1313582B1 (en) 1999-07-30 1999-07-30 New pressured metered dose inhalers (MDI) in which all the internal surfaces of the inhalers are stainless steel, anodised aluminum or are lined with an inert organic coating are new
PCT/EP1999/009002 WO2000030608A1 (en) 1998-11-25 1999-11-23 Pressurised metered dose inhalers (mdi)

Publications (2)

Publication Number Publication Date
EE200100276A true EE200100276A (en) 2002-12-16
EE04259B1 EE04259B1 (en) 2004-04-15

Family

ID=26331622

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100276A EE04259B1 (en) 1998-11-25 1999-11-23 Pressurized metered dose inhalers (MDI)

Country Status (34)

Country Link
US (8) US7347199B1 (en)
EP (4) EP1666029A1 (en)
JP (1) JP2002530156A (en)
CN (1) CN1200690C (en)
AR (1) AR021391A1 (en)
AT (2) AT485812T (en)
AU (1) AU764696C (en)
BG (1) BG65596B1 (en)
BR (1) BR9916868B1 (en)
CA (2) CA2698376A1 (en)
CO (1) CO5170487A1 (en)
CZ (1) CZ301305B6 (en)
DE (3) DE69942896D1 (en)
DK (1) DK1131051T3 (en)
DZ (1) DZ2947A1 (en)
EA (1) EA004132B1 (en)
EE (1) EE04259B1 (en)
EG (1) EG25278A (en)
ES (1) ES2255767T3 (en)
GE (1) GEP20033129B (en)
HK (1) HK1040063A1 (en)
HU (1) HU226735B1 (en)
IL (3) IL143294D0 (en)
MA (1) MA26764A1 (en)
NO (1) NO330194B1 (en)
NZ (2) NZ527190A (en)
PL (2) PL204572B1 (en)
SA (1) SA1536B1 (en)
SI (1) SI1131051T1 (en)
SK (1) SK285246B6 (en)
TN (1) TNSN99220A1 (en)
TR (2) TR200704956T2 (en)
TW (1) TWI226247B (en)
WO (1) WO2000030608A1 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa pressurized meter dose inhaler.
US6739333B1 (en) 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulations optimized consist of dasomministrare steroids solutions for inhalation.
IT1317720B1 (en) * 2000-01-07 2003-07-15 Chiesi Farma Spa A device for the administration of pressurized metered dose aerosol inpropellenti hydrofluoroalkanes.
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulations containing an anticholinergic drug for chronic obstructive pulmonary disease trattamentodella.
IT1318514B1 (en) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulations containing a glucocorticosteroid drug iltrattamento of bronchopulmonary diseases.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
ME00220B (en) 2000-05-22 2010-10-10 Chiesi Farm Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
DE10062712A1 (en) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma New pharmaceutical compositions based on anticholinergics and corticosteroids
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
EP1241113A1 (en) * 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
PT1273292E (en) * 2001-07-02 2004-10-29 Chiesi Farma Spa Optimized tobramycin formulation for aerosolization
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PL209212B1 (en) * 2002-03-01 2011-08-31 Chiesi Farmaceutici S.P.A. Formoterol superfine formulation
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
DK1608336T3 (en) 2003-03-20 2008-06-02 Boehringer Ingelheim Pharma A formulation for a metered dose inhaler with hydrofluorakaner as propellants
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
DE602004030913D1 (en) 2003-06-24 2011-02-17 Cipla Ltd A device for post of pharmaceutical products
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
DE10345065A1 (en) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg An aerosol formulation for inhalation containing an anticholinergic
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
CN100457087C (en) 2004-02-27 2009-02-04 奇斯药制品公司 Stable pharmaceutical solution formulation for pressurized metered dose inhalers
KR20070000476A (en) * 2004-02-27 2007-01-02 키에시 파르마슈티시 엣스. 피. 에이. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
AU2005259523B2 (en) 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
KR101313959B1 (en) 2005-02-25 2013-10-02 키에시 파르마슈티시 엣스. 피. 에이. Phamaceutical Aerosol Formulations for Pressurized Metered Dose Inhalers comprising a Sequestering Agent
CA2603433A1 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
DE102006017320A1 (en) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg A suspension aerosol formulations with TG 227 ea or TG 134 as a blowing agent
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
BR112012023877A2 (en) 2010-03-15 2016-08-02 Univ Virginia Commonwealth aerosolized dapsone as a therapy for airway inflammation and abnormal mucociliary transport
NZ605920A (en) * 2010-07-16 2015-01-30 Cipla Ltd Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators
TWI399202B (en) 2011-03-17 2013-06-21 Intech Biopharm Ltd The preparation for formulation composition and manufacturing processes of metered dose inhalers treated respiratory diseases
CN102379846B (en) * 2011-10-21 2014-07-02 江苏长风药业有限公司 Fluticasone propionate aerosol preparation with hydrofluoroalkane and polyethylene glycol as auxiliary materials
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
CN103207032A (en) * 2012-01-13 2013-07-17 热敏碟公司 Low-profile temperature sensor probe
KR101313993B1 (en) * 2012-07-24 2013-10-01 한국화학연구원 Nebulizer
DE102013214601B3 (en) * 2013-07-25 2014-05-22 Aptar Radolfzell Gmbh Housing for container unit of inhalation device e.g. metered-dose inhaler, for oral administration of pharmaceutical medium, has membrane reversibly deformed based on pressure in pressure chamber and acting together with pushbutton
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN106620976A (en) * 2016-12-28 2017-05-10 四川普锐特医药科技有限责任公司 Fluticasone propionate aerosol realizing quantitative inhalation
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US154013A (en) * 1874-08-11 Improvement in carriage-lamps
US220718A (en) * 1879-10-21 Improvement in street-car warmers
BE555319A (en) * 1956-03-21 1900-01-01
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
CA882187A (en) 1968-03-13 1971-09-28 Farbenfabriken Bayer Aktiengesellschaft Thermoplastic-elastic moulding compounds
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (en) 1975-05-27 1981-08-26 Syntex Corp A process for preparing 6-fluiro 11b-21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3-20 crystalline compound dione
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (en) 1984-06-11 1988-11-10 Sicor Spa Process for the preparation of 16,17-acetals of pregnane derivatives and new compounds obtained
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Aerosol propellant compositions
AU642970B2 (en) 1990-02-14 1993-11-04 Systec Ausbausysteme Gmbh Trolley with coin lock
IT1244441B (en) * 1990-09-13 1994-07-15 Chiesi Farma Spa A device for inhalation buccal aerosol medications
WO1992011236A1 (en) * 1990-12-19 1992-07-09 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DK0585379T3 (en) 1991-05-21 1999-06-21 Abbott Lab The aerosol inhalation device
DE59209686D1 (en) * 1991-08-29 1999-06-02 Broncho Air Medizintechnik Ag A medical device for inhalation of aerosol-dosier
NZ244439A (en) 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
US5219882A (en) 1991-10-24 1993-06-15 Emil Bisaccia Treatment methods for lymes disease and associated debilitating conditions
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
EP0617610B1 (en) 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
DE4230876A1 (en) 1992-03-17 1993-09-23 Asta Medica Ag Aerosols of using polyoxyethylene glyceryl oleates
RO117414B1 (en) 1992-12-09 2002-03-29 Jager Paul D Waterbury Pharmaceutical composition of gas dispersoid in solution
SE9203743D0 (en) 1992-12-11 1992-12-11 Astra Ab Efficient use
WO1994014490A1 (en) 1992-12-23 1994-07-07 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
CA2156408C (en) 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid
AU679510B2 (en) 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
CA2178473C (en) * 1993-12-20 2004-08-24 Tsi-Zong Tzou Flunisolide aerosol formulations
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
IL116460A (en) 1994-12-22 2003-10-31 Astra Ab Aerosol drug formulations for inhalation and method for their preparation
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (en) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stable aqueous budesonide solution
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
EA000889B1 (en) * 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Beclomethasone dipropionate metered dose inhaler
PT820322E (en) * 1995-04-14 2002-10-31 Smithkline Beecham Corp Dossier inhaler for fluticasone propionate
PL180901B1 (en) * 1995-04-14 2001-04-30 Glaxo Wellcome Inc. Salmeterol inhaler with dosis metering feature
CA2391617A1 (en) * 1995-04-14 1996-10-17 Smithkline Beecham Corporation Pharmaceutical preparation and use
US5637505A (en) * 1995-05-19 1997-06-10 Chiron Diagnostics Corporation Method to prepare dye-based reference material
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
AU3453897A (en) 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
AU3811897A (en) 1996-07-24 1998-02-10 Oglios Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
AU726510B2 (en) * 1996-12-04 2000-11-09 Consort Medical Plc Pharmaceutical compositions and devices for their administration
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
AUPO429396A0 (en) * 1996-12-20 1997-01-23 Solsearch Pty Ltd Solar energy collector system
DE59804534D1 (en) 1997-02-05 2002-07-25 Jago Res Ag Muttenz Medical aerosol formulations
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
EP0991734B1 (en) 1997-06-12 2001-08-29 PAC Holding S.A. Method for the disposal of waste products containing hydrocarbons and/or halogenated waste products
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (en) 1997-09-05 1999-09-14 Chiesi Farma Spa Spray nozzle for use in oral medicines for aerosol inhaler
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6086379A (en) * 1998-10-20 2000-07-11 Research Foundation Of State University Of New York System and method for training a swimmer
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
DK1087750T3 (en) 1998-06-18 2004-01-26 Boehringer Ingelheim Pharma Pharmaceutical formulations for aerosols with two or more active substances,
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ES2234266T3 (en) 1998-07-24 2005-06-16 Jago Research Ag medical aerosol formulations.
CN1150890C (en) 1998-08-04 2004-05-26 杰格研究股份公司 Medicinal aerosol formulations
DE19847969A1 (en) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation
DE59901669D1 (en) 1998-10-17 2002-07-11 Boehringer Ingelheim Pharma A storable drug concentrate with formoterol
DK1131059T3 (en) 1998-11-13 2003-06-30 Jago Res Ag A dry powder for inhalation
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa pressurized meter dose inhaler.
IT1303788B1 (en) * 1998-11-25 2001-02-23 Chiesi Farma Spa Aerosol formulations of medicines.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
BR9917246A (en) 1999-03-05 2002-03-26 Chiesi Farma Spa Advanced powder pharmaceutical compositions for inhalation
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AT291898T (en) 1999-12-24 2005-04-15 Glaxo Group Ltd A pharmaceutical aerosol formulation comprising salmeterol and fluticasone
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulations containing an anticholinergic drug for chronic obstructive pulmonary disease trattamentodella.
IT1318514B1 (en) 2000-05-12 2003-08-27 Chiesi Farma Spa Formulations containing a glucocorticosteroid drug iltrattamento of bronchopulmonary diseases.
ME00220B (en) * 2000-05-22 2010-10-10 Chiesi Farm Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
PT1273292E (en) * 2001-07-02 2004-10-29 Chiesi Farma Spa Optimized tobramycin formulation for aerosolization
PL209212B1 (en) 2002-03-01 2011-08-31 Chiesi Farmaceutici S.P.A. Formoterol superfine formulation
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
US6808684B2 (en) 2002-04-05 2004-10-26 International Flavors & Fragrance Inc. Fragrance material
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
NO20012516D0 (en) 2001-05-22
EP1523975A3 (en) 2005-08-31
GEP20033129B (en) 2003-05-12
PL204572B1 (en) 2010-01-29
TWI226247B (en) 2005-01-11
US20050142071A1 (en) 2005-06-30
NZ527190A (en) 2005-04-29
US20110100361A1 (en) 2011-05-05
PL348717A1 (en) 2002-06-03
EA200100468A1 (en) 2001-12-24
AT314838T (en) 2006-02-15
TNSN99220A1 (en) 2001-12-31
US8142763B2 (en) 2012-03-27
CN1328445A (en) 2001-12-26
TR200101441T2 (en) 2001-08-21
EE04259B1 (en) 2004-04-15
CN1200690C (en) 2005-05-11
EP1131051B1 (en) 2006-01-04
AU764696B2 (en) 2003-08-28
AU764696C (en) 2004-06-24
BR9916868B1 (en) 2011-02-08
CO5170487A1 (en) 2002-06-27
BR9916868A (en) 2001-11-06
CA2698376A1 (en) 2000-06-02
DE69929358T2 (en) 2006-07-13
IL179491D0 (en) 2007-05-15
US7223381B2 (en) 2007-05-29
EP1523975A2 (en) 2005-04-20
EP1666029A1 (en) 2006-06-07
MA26764A1 (en) 2004-12-20
EA004132B1 (en) 2003-12-25
AT485812T (en) 2010-11-15
CA2352484A1 (en) 2000-06-02
AU1556300A (en) 2000-06-13
DE29923839U1 (en) 2001-03-01
IL143294D0 (en) 2002-04-21
HU0104411A3 (en) 2002-12-28
US20030066525A1 (en) 2003-04-10
NO20012516L (en) 2001-07-23
NZ511926A (en) 2003-10-31
NO330194B1 (en) 2011-03-07
CZ20011834A3 (en) 2001-12-12
SK7042001A3 (en) 2001-11-06
US20040096399A1 (en) 2004-05-20
HU226735B1 (en) 2009-08-28
PL200658B1 (en) 2009-01-30
HK1040063A1 (en) 2006-04-21
US20030089369A1 (en) 2003-05-15
CZ301305B6 (en) 2010-01-06
SK285246B6 (en) 2006-09-07
HU0104411A2 (en) 2002-03-28
AR021391A1 (en) 2002-07-17
EP1523975B1 (en) 2010-10-27
TR200704956T2 (en) 2008-01-21
US20080247965A1 (en) 2008-10-09
US7347199B1 (en) 2008-03-25
CA2352484C (en) 2010-05-04
DE69942896D1 (en) 2010-12-09
EP1674079A2 (en) 2006-06-28
SA1536B1 (en) 2006-11-07
EG25278A (en) 2011-12-05
DZ2947A1 (en) 2004-03-15
DK1131051T3 (en) 2006-04-18
BG65596B1 (en) 2009-02-27
SI1131051T1 (en) 2006-04-30
WO2000030608A1 (en) 2000-06-02
IL143294A (en) 2007-05-15
US20080115782A1 (en) 2008-05-22
EP1674079A3 (en) 2006-07-05
US7740463B2 (en) 2010-06-22
DE69929358D1 (en) 2006-03-30
ES2255767T3 (en) 2006-07-01
JP2002530156A (en) 2002-09-17
BG105532A (en) 2001-12-31
EP1131051A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
DE69618624T2 (en) inhaler
DK1119334T3 (en) Dual-chamber cartridge for atomizer
DK1011552T3 (en) Externally arranged medicated næsedilator
DE69924615D1 (en) Thymosin beta 4 stimulates wound healing
DK0835149T3 (en) An inhaler as well as the method for delivering a substance for inhalation
DE69923076D1 (en) Transthoracic drug delivery device
DE69841184D1 (en) nasal mask
DE69420412D1 (en) Therapeutic inhalation preparation
DK0883415T3 (en) An inhaler for powdered medicament
TR199501673A1 (en) Aerosol drug formulations.
DK1649886T3 (en) Unit dose Capsules for törpulverinhalatorer
DK1140027T3 (en) Dosage forms containing particles poröse
DE19581697T1 (en) Drug dispenser with applicator for single patient doses
NO20020464D0 (en) The multicomponent pharmaceutical dosage forms
DK0830170T3 (en) Automated infusion dose rate calculator
EE200100714A (en) The pharmaceutical dosage forms methods pihustamissüsteemidja
ID24653A (en) Therapeutic substances
DK0615762T3 (en) Dosage Spray
NO993348L (en) The inhalation device
DK0820322T3 (en) Metered dose inhaler Fluticasone Propionate
DK1225943T3 (en) Inner hvirvelströmsmekanisme for inhalation
ID23299A (en) Pharmaceutical formulations
NO994564L (en) dry powder inhalers
NO320434B1 (en) Pharmaceutical compositions comprising proliposompulvere for inhalation
DE69503499D1 (en) powder inhaler

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231